Consolidated Financial Statements

Bayer Group Consolidated Statements of Comprehensive Income

 

 

Note

 

2017

 

2018

 

 

 

 

€ million

 

€ million

1

Other comprehensive income is recognized outside profit or loss in equity.

Income after income taxes

 

 

 

8,094

 

1,711

of which attributable to noncontrolling interest

 

[12]

 

758

 

16

of which attributable to Bayer AG stockholders

 

 

 

7,336

 

1,695

Remeasurements of the net defined benefit liability for post-employment benefit plans

 

[22]

 

1,236

 

(612)

Income taxes

 

[11]

 

(515)

 

129

Other comprehensive income from remeasurements of the net defined benefit liability for post-employment benefit plans

 

 

 

721

 

(483)

Change in the fair value of own credit risk component of financial liabilities measured at fair value

 

 

 

 

(6)

Income taxes

 

[11]

 

 

2

Other comprehensive income relating to own credit risk component of financial liabilities measured at fair value

 

 

 

 

(4)

Other comprehensive income from equity instruments measured at fair value

 

 

 

 

46

Other comprehensive income relating to associates accounted for using the equity method

 

 

 

(44)

 

19

Other comprehensive income that will not be reclassified subsequently to profit or loss

 

 

 

677

 

(422)

Changes in fair values of derivatives designated as cash flow hedges

 

[27]

 

(144)

 

125

Reclassified to profit or loss

 

 

 

3

 

124

Income taxes

 

[11]

 

53

 

(80)

Other comprehensive income from cash flow hedges

 

 

 

(88)

 

169

Changes in fair values of available-for-sale financial assets

 

[17]

 

(3)

 

Reclassified to profit or loss

 

 

 

(2)

 

Income taxes

 

[11]

 

3

 

Other comprehensive income from available-for-sale financial assets

 

 

 

(2)

 

Changes in exchange differences recognized on translation of operations outside the eurozone

 

 

 

(2,152)

 

1,008

Reclassified to profit or loss

 

 

 

 

118

Other comprehensive income from exchange differences

 

 

 

(2,152)

 

1,126

Other comprehensive income relating to associates accounted for using the equity method

 

 

 

101

 

1

Other comprehensive income that may be reclassified subsequently to profit or loss

 

 

 

(2,141)

 

1,296

Total other comprehensive income1

 

 

 

(1,464)

 

874

of which attributable to noncontrolling interest

 

 

 

(106)

 

(8)

of which attributable to Bayer AG stockholders

 

 

 

(1,358)

 

882

Total comprehensive income

 

 

 

6,630

 

2,585

of which attributable to noncontrolling interest

 

 

 

652

 

8

of which attributable to Bayer AG stockholders

 

 

 

5,978

 

2,577

Compare to Last Year